BioSpace News Archive

ARTMS Products Inc . (ARTMS), a global leader in the development of novel technologies enabling the production of the world’s highest demand diagnostic imaging isotopes, and Telix Pharmaceuticals Limited (Telix), a clinical-stage biopharmaceutical company developing diagnostic and therapeutic products using Molecularly Targeted Radiation (MTR) announced today they have entered into a development

Allovate Therapeutics , a New York-based biotechnology company, announced today that it is making its allergy immunotherapy delivery platform available without charge to allergy professionals facing difficulties bringing their patients into the office for injections. Allovate was founded in 2012 with the goal of improving and advancing the administration of allergy immunotherapy for patients of all ages. Allovate’s lead product, Allerdent ® , is

Neogen Corporation (Nasdaq: NEOG) announced today that Health Canada has granted temporary approval for Neogen to supply Neogen® Viroxide Super disinfectant to aid in the country’s fight against COVID-19.

Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most important unmet patient needs, today announced financial results for the three months ended March 31, 2020 and highlighted recent corporate updates.

Otezla Treatment Resulted in Significant Improvements in Measures of Mild-to-Moderate Psoriasis Compared With Placebo Data Will be Submitted to the U.S. Food and Drug Administration (FDA) for Inclusion in Otezla Prescribing Information

Oncosec Medical Incorporated (the “Company” or “Oncosec”) (Nasdaq: ONCS), a company developing late-stage intratumoral cancer immunotherapies, today announced published data in Clinical Cancer Research, linked here, that demonstrated its lead product candidate, TAVO™ (interleukin-12 or “IL-12" plasmid), in combination with the anti-PD-1 checkpoint inhibitor KEYTRUDA

Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoid medicine focused on cancer and its side effects, announced today that it has filed a Provisional Patent Application with the US Patent & Trademark Office (USPTO) entitled “Composition and Method for Treating Colon Cancer with

BERG, a clinical-stage biotech company that uses artificial intelligence (AI) to research diseases and develop innovative treatments, today announced a new collaboration with Boehringer Ingelheim around understanding the multifaceted nature of the spectrum of inflammatory diseases and seeks to unravel the associated biological drivers.

The Galien Foundation announced today upcoming events throughout the year, including the annual Galien Forum and Prix Galien USA Ceremony, the biennial Prix Galien International, the inaugural Prix Galien Africa and the Prix Galien Golden Jubilee, which culminates the Foundation’s 50 years of celebration of innovation across the globe.

AliveCor , the leader in AI-based personal ECG technology and provider of enterprise cardiology solutions, announced a strategic collaboration with the Clifford Lab at Emory University School of Medicine , and the Geor